p53 deacetylation by SIRT1 decreases during protein kinase CKII downregulation-mediated cellular senescence

被引:21
作者
Jang, Seok Young [1 ]
Kim, Soo Young [1 ]
Bae, Young-Seuk [1 ]
机构
[1] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci & Biotechnol, Taegu 702701, South Korea
基金
新加坡国家研究基金会;
关键词
p53; Acetylation; SIRT1; Protein kinase CKII; Senescence; Tumor suppression; HUMAN FIBROBLASTS; PREMATURE SENESCENCE; ONCOGENIC RAS; CANCER-CELLS; CK2; TUMORIGENESIS; P16(INK4A); INHIBITORS;
D O I
10.1016/j.febslet.2011.09.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular senescence is thought to be an important tumor suppression process in vivo. We have previously shown that p53 activation is necessary for CKII inhibition-mediated cellular senescence. Here, CKII inhibition induced acetylation of p53 at K382 in HCT116 and HEK293 cells. This acetylation event was suppressed by SIRT1 activation. CKII alpha and CKII beta were co-immunoprecipitated with SIRT1 in a p53-independent manner. Maltose binding protein pull-down and yeast two-hybrid indicated that SIRT1 bound to CKII beta, but not to CKII alpha. CKII inhibition reduced SIRT1 activity in cells. CKII phosphorylated and activated human SIRT1 in vitro. Finally, SIRT1 overexpression antagonized CKII inhibition-mediated cellular senescence. These results reveal that CKII downregulation induces p53 stabilization by negatively regulating SIRT1 deacetylase activity during senescence. Structured summary of protein interactions: CKII Beta binds to SIRT1 by pull down (View interaction) CKII Beta physically interacts with SIRT1 by pull down (View interaction) SIRT1 physically interacts with CKII Beta and CKII Alpha by anti bait coimmunoprecipitation (View Interaction: 1, 2, 3) CKII Beta physically interacts with SIRT1 by two hybrid (View interaction) (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:3360 / 3366
页数:7
相关论文
共 27 条
[1]  
APPEL K, 1995, ONCOGENE, V11, P1971
[2]   HUMAN-SKIN FIBROBLASTS INVITRO DIFFERENTIATE ALONG A TERMINAL CELL LINEAGE [J].
BAYREUTHER, K ;
RODEMANN, HP ;
HOMMEL, R ;
DITTMANN, K ;
ALBIEZ, M ;
FRANCZ, PI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5112-5116
[3]   Post-translational modification of p53 in tumorigenesis [J].
Bode, AM ;
Dong, ZG .
NATURE REVIEWS CANCER, 2004, 4 (10) :793-805
[4]   How does SIRT1 affect metabolism, senescence and cancer? [J].
Brooks, Christopher L. ;
Gu, Wei .
NATURE REVIEWS CANCER, 2009, 9 (02) :123-128
[5]   Bypass of senescence after disruption of p21(CIP1/WAF1) gene in normal diploid human fibroblasts [J].
Brown, JP ;
Wei, WY ;
Sedivy, JM .
SCIENCE, 1997, 277 (5327) :831-834
[6]   Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts:: p53 and Rb control G1 arrest but not cell replication [J].
Chen, QM ;
Bartholomew, JC ;
Campisi, J ;
Acosta, M ;
Reagan, JD ;
Ames, BN .
BIOCHEMICAL JOURNAL, 1998, 332 :43-50
[7]   A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO [J].
DIMRI, GP ;
LEE, XH ;
BASILE, G ;
ACOSTA, M ;
SCOTT, C ;
ROSKELLEY, C ;
MEDRANO, EE ;
LINSKENS, M ;
RUBELJ, I ;
PEREIRASMITH, O ;
PEACOCKE, M ;
CAMPISI, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9363-9367
[8]   Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2 [J].
Duncan, James S. ;
Litchfield, David W. .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (01) :33-47
[9]   REPLICATIVE SENESCENCE - THE HUMAN FIBROBLAST COMES OF AGE [J].
GOLDSTEIN, S .
SCIENCE, 1990, 249 (4973) :1129-1133
[10]   MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation [J].
Ito, A ;
Kawaguchi, Y ;
Lai, CH ;
Kovacs, JJ ;
Higashimoto, Y ;
Appella, E ;
Yao, TP .
EMBO JOURNAL, 2002, 21 (22) :6236-6245